Clinical trials
Phase 4 Macular Degeneration trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
84 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 2 |
| 2006 | 6 |
| 2007 | 6 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 7 |
| 2011 | 2 |
| 2012 | 7 |
| 2013 | 5 |
| 2014 | 10 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 52 |
| Unknown status | 17 |
| Terminated | 8 |
| Withdrawn | 2 |
| Recruiting | 2 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 12 |
| Bayer | 3 |
| Eyetech Pharmaceuticals | 3 |
| Novartis | 3 |
| Unity Health Toronto | 3 |
| David M. Brown, M.D. | 2 |
| Formycon AG | 2 |
| Illinois Retina Associates | 2 |
| Kim's Eye Hospital | 2 |
| Pfizer | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Macular Degeneration | 84 |
| Choroidal Neovascularization | 16 |
| Retinal Vein Occlusion | 8 |
| Wet Macular Degeneration | 8 |
| Geographic Atrophy | 7 |
| Vision Disorders | 6 |
| Diabetic Retinopathy | 4 |
| Polypoidal Choroidal Vasculopathy | 4 |
| Eye Diseases | 3 |
| Macular Edema | 3 |
Trials
Showing 76 to 84 of 84. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.